This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
By This Author:
« Back
Page 1 of 101

Medco Deal Fuels Health Care's Hot Streak

By Jake Lynch

There are strong investing opportunities in the health care sector.

11:19AM 07/21/11

Goldman Likes BlackRock, But Loves Principal

By Jake Lynch

BlackRock beats estimates, but Principal is a better buy.

02:12PM 07/20/11

Microsoft, Intel Are Buys Ahead of Earnings

By Jake Lynch

Microsoft and Intel, due to report, are attractive investments.

02:49PM 07/19/11

Top Gold Stocks to Consider Now

By Jake Lynch

Royal Gold is the top-ranked gold stock at TheStreet.

02:56PM 07/18/11

Pepsi's Junk-Food Empire Can't Beat Coke

By Jake Lynch

Coke's volume strategy may be a long-run winner.

06:00AM 07/18/11

Buy Dow Growth Stocks on Debt-Ceiling Fear

By Jake Lynch

Energy and industrial Dow components are attractive.

01:22PM 07/14/11

Don't Count Out Google the Innovator

By Jake Lynch

Google is a compelling technology investment under Larry Page.

06:30AM 07/14/11

Cisco Gets Leaner and Meaner -- Finally

By Jake Lynch

Cisco is shedding jobs and refocusing its business.

11:16AM 07/12/11

Dunkin' IPO Flies in Face of Social-Media Buzz

By Jake Lynch

Dunkin' growth potential may outstrip that of Starbucks.

01:19PM 07/11/11

How to Make Money Off Oil, Gas Pains

By Jake Lynch

Oil and gas stocks have been top performers and will extend gains.

06:30AM 07/11/11

« Back
Page 1 of 101

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs